NCT05889897

Brief Summary

This study is aimed to identify the prevalence, risk factors and outcomes of children with either venous or arterial thromboembolism admitted to children hospital Assiut University aiming at early detection and avoidance of catastrophic complications .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 5, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

July 18, 2023

Status Verified

July 1, 2023

Enrollment Period

8 months

First QC Date

March 26, 2023

Last Update Submit

July 15, 2023

Conditions

Vascular Thrombosis

Outcome Measures

Primary Outcomes (2)

  • Number of pediatrics with vascular thrombosis

    This study is aimed to identify the prevalence of children with either venous or arterial thromboembolism admitted to children hospital Assiut University aiming at early detection and avoidance of catastrophic complications

    baseline

  • Number of risk factors of pediatric vascular thrombosis

    This study is aimed to identify risk factors of children with either venous or arterial thromboembolism admitted to children hospital Assiut University aiming at early detection and avoidance of catastrophic complications

    Baseline

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

15 infant aged from 1 day to 18 years with vascular thrombosis

You may qualify if:

  • Age : From 1day to 18 years.
  • Sex : Both genders.
  • Confirmed diagnosed cases, either Symptomatic or asymptomatic venous and arterial thromboembolism established by an imaging study.
  • All patients admitted to the different units of children hospital including surgical unit.

You may not qualify if:

  • Age more than 18 years.
  • Patient Known to have Sickle cell disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Thrombosis

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Maher Mokhtar, Prof

    Assiut University

    PRINCIPAL INVESTIGATOR

  • Mervat Amin, Assist Prof

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Doaa sayed

CONTACT

01064884771nananony551996@gmail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

March 26, 2023

First Posted

June 5, 2023

Study Start

August 1, 2023

Primary Completion

April 1, 2024

Study Completion

July 1, 2024

Last Updated

July 18, 2023

Record last verified: 2023-07